COPD Disease. Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive 2 tablets of 60 mg coccitone for 6 weeks each day. Intervention 2: Control group: The control group received 2 tablets of starc
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: At least 18 years of age, no nutritional and pharmaceutical supplementation, and informed consent.
Exclusion criteria
Exclusion criteria: diagnosis of mellitus diabetes, PTE, CKD, CAD and bacterial pneumonia or taking any complementary medicines.Also diagnosis of COPD with current treatment of antioxidant medicine and supplements or any medicine that affects antioxidant storage and mitocondrial system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of antioxidants in the serum of patients. Timepoint: Before the intervention placebo and 6 weeks after starting the Coq10 capsule. Method of measurement: thiobarbituric acid method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum levels of antioxidants in the serum of patients. Timepoint: 6 weeks after taking the supplement or placebo. Method of measurement: thiobarbituric acid method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZabihullah mohaghegh
Birjand University of Medical Sciences
Outcome results
None listed